Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove
Biomarkers of Systemic Treatment Outcomes in Psoriasis (BSTOP) Study Group, Tsakok, T., Saklatvala, J., Rispens, T., Loeff, F. C., de Vries, A., Allen, M. H., Barbosa, I. A., Baudry, D., Dasandi, T., Duckworth, M., Meynell, F., Russell, A., Chapman, A., McBride, S., McKenna, K., Perera, G., Ramsay, H., Ramesh, R. & Sands, K. & 10 others, , 22 Feb 2023, In: JCI Insight. 8, 4, e156643.
Research output: Contribution to journal › Article › peer-review
